S

Shaperon

16 employees

Shaperon is a clinical-stage biotech company that develops inflammasome inhibitors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
코로나19치료제
항염증제
Alzheimer
패혈증
oncology
Atopy
DAMPs
Immunology
면역학
inflammation
나노바디
항체치료제
항암
인플라마좀
immune
염증복합체 억제제
colon cancer
nanobody
TGR5
stomach cancer
면역항암제
알츠하이머
Biopharma
아토피 피부염
sepsis
Ulcerative colitis

Date founded

2008

Funding rounds raised

Total raised

$23M

from 2 investors over 2 rounds

S

Shaperon raised $23M on October 20, 2020

Investors: Yuanta Investment Korea (유안타인베스트먼트) and Smilegate Investment

FAQ